» Articles » PMID: 18810458

[Anterior Ischemic Optic Neuropathy: Etiology, Pathogenetic Mechanisms and Therapy]

Overview
Journal Ophthalmologe
Specialty Ophthalmology
Date 2008 Sep 24
PMID 18810458
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic optic neuropathy is caused by ischemia of the optic nerve head in the region of the lamina cribrosa. Differentiation is made between arteritic (AION) and nonarteritic (NAION) forms. AION is the most common ophthalmological manifestation of giant cell arteritis and is usually well controlled with systemic steroid therapy. Temporal artery biopsy for confirmation of the diagnosis is mandatory. NAION is not a disease entity but rather the common pathogenetic pathway of a large variety of diseases and conditions and is often the result of several interacting factors. For this reason, there is no "standard therapy" for NAION. Careful interdisciplinary work up in NAION frequently reveals previously unrecognized diseases requiring treatment according to internal medicine standards. Adequate treatment frequently results in improvement of the affected eye and reduced risk of NAION in the other eye or of brain infarction.

Citing Articles

[Optic disc swelling : A compilation of relevant differential diagnoses].

Prokosch V, Dragnea D, Pitz S Ophthalmologe. 2016; 113(11):967-981.

PMID: 27624145 DOI: 10.1007/s00347-016-0353-2.


Recovery of visual function after administration of dabigatran etexilate.

Schonfeld C, Fischer M, Distelmaier P, Philipp S, Paquet P, Haller K Case Rep Ophthalmol. 2014; 5(2):262-6.

PMID: 25232340 PMC: 4163691. DOI: 10.1159/000365961.


[Bilateral anterior ischemic optic neuropathy following EHEC sepsis and hemolytic-uremic syndrome].

Wortmann T, Jagle H, Hufendiek K Ophthalmologe. 2012; 110(7):668-70.

PMID: 23242104 DOI: 10.1007/s00347-012-2746-1.


[Ophthalmological findings as a hint for systemic disease].

Herrmann W, Helbig H, Gamulescu M Internist (Berl). 2010; 51(4):473-81.

PMID: 20195561 DOI: 10.1007/s00108-009-2454-3.


[Retrospective case analysis of ophthalmological and systemic risk factors in patients with retinal vascular occlusion].

Klatt C, Purtskhvanidze K, Hasselbach H, Treumer F, Hillenkamp J, Roider J Ophthalmologe. 2009; 107(5):446-51.

PMID: 19756639 DOI: 10.1007/s00347-009-2018-x.

References
1.
Unsold R . [Neuropathies of the optic nerve in inflammatory systemic diseases and vasculitis. A frequently misdiagnosed early symptom]. Ophthalmologe. 1994; 91(2):251-62. View

2.
BURDE R . Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1993; 116(6):759-64. DOI: 10.1016/s0002-9394(14)73478-6. View

3.
Mas J, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G . Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001; 345(24):1740-6. DOI: 10.1056/NEJMoa011503. View

4.
Hayreh S, Zimmerman M . Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008; 246(7):1029-46. PMC: 2712323. DOI: 10.1007/s00417-008-0805-8. View

5.
Stammen J, Unsold R, Arendt G, Vester E, Heering P, Freund H . Etiology and pathogenetic mechanisms of optic disc swelling with visual loss. An interdisciplinary prospective pilot study of 102 cases. Ophthalmologica. 1998; 213(1):40-7. DOI: 10.1159/000027392. View